Weiwei Li

830 total citations
44 papers, 631 citations indexed

About

Weiwei Li is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Weiwei Li has authored 44 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 10 papers in Surgery and 8 papers in Epidemiology. Recurrent topics in Weiwei Li's work include Cancer-related Molecular Pathways (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Weiwei Li is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Weiwei Li collaborates with scholars based in China, United States and Australia. Weiwei Li's co-authors include Benjamin F. Cravatt, Jacqueline L. Blankman, Joseph R. Bertino, Jian‐Gao Fan, Naoto Takahashi, Carlos Cordon‐Cardo, Glynn Faircloth, S.C. Jhanwar, Y Elisseyeff and Daniel Hochhauser and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Weiwei Li

41 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiwei Li China 14 281 227 106 96 91 44 631
Kunihiko Tatsumi Japan 8 296 1.1× 282 1.2× 94 0.9× 149 1.6× 66 0.7× 8 663
María José Muñoz-Alonso Spain 15 604 2.1× 262 1.2× 113 1.1× 35 0.4× 67 0.7× 22 840
Maria Grazia Prisco Italy 16 310 1.1× 316 1.4× 117 1.1× 79 0.8× 34 0.4× 22 761
Seog-Nyeon Bae South Korea 8 155 0.6× 151 0.7× 116 1.1× 48 0.5× 41 0.5× 10 499
Yi Ming Mu China 9 405 1.4× 165 0.7× 117 1.1× 59 0.6× 62 0.7× 11 623
Wei Wei Prior United States 8 644 2.3× 199 0.9× 91 0.9× 147 1.5× 25 0.3× 10 888
Mary Jo Pilat United States 12 407 1.4× 230 1.0× 143 1.3× 68 0.7× 69 0.8× 25 669
Roos L. Oostendorp Netherlands 11 544 1.9× 332 1.5× 102 1.0× 43 0.4× 41 0.5× 15 987
Wei Jing China 16 341 1.2× 269 1.2× 111 1.0× 199 2.1× 68 0.7× 45 694
Dianren Xia United States 10 314 1.1× 114 0.5× 120 1.1× 46 0.5× 29 0.3× 17 487

Countries citing papers authored by Weiwei Li

Since Specialization
Citations

This map shows the geographic impact of Weiwei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Li more than expected).

Fields of papers citing papers by Weiwei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Li. The network helps show where Weiwei Li may publish in the future.

Co-authorship network of co-authors of Weiwei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Li. A scholar is included among the top collaborators of Weiwei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Li. Weiwei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frew, Adam, et al.. (2025). Contrasting effects of above and belowground litter inputs in shaping the soil microbiome worldwide. Plant and Soil. 515(1). 363–375. 1 indexed citations
2.
Lin, Qiaohong, Xian Du, Ying Liu, et al.. (2025). Anti-Müllerian hormone signalling sustains circadian homeostasis in zebrafish. Nature Communications. 16(1). 4359–4359.
3.
4.
Ma, Yuxiang, Huaqiang Zhou, Fan Luo, et al.. (2024). Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinoma. npj Precision Oncology. 8(1). 65–65. 6 indexed citations
5.
Li, Weiwei, et al.. (2024). Comparative effectiveness of several adjuvant therapies after hepatectomy for hepatocellular carcinoma patients with microvascular invasion. World Journal of Gastrointestinal Surgery. 16(2). 554–570. 1 indexed citations
6.
Li, Weiwei, et al.. (2023). Long term prophylactic anticoagulation for portal vein thrombosis after splenectomy: A systematic review and meta-analysis. PLoS ONE. 18(8). e0290164–e0290164. 1 indexed citations
7.
Wu, Zehua, Huaiming Wang, Dian Liu, et al.. (2023). Distinct Clinicopathological Features and Prognostic Values of High-, Low-, or Non-Expressing HER2 Status in Colorectal Cancer. Cancers. 15(2). 554–554. 4 indexed citations
8.
Li, Weiwei, et al.. (2022). Clinical value of AKR1B10 in hepatocellular carcinoma: A systematic review and meta-analysis. PLoS ONE. 17(12). e0279591–e0279591. 8 indexed citations
9.
Feng, Yun, Yiming Zhao, Weiwei Li, et al.. (2022). Hepatic resection prolongs overall survival in the selected patients with nasopharyngeal carcinoma liver metastases. European Journal of Surgical Oncology. 48(10). 2202–2211. 3 indexed citations
10.
Li, Weiwei, et al.. (2022). Successful conversion therapy for unresectable hepatocellular carcinoma is getting closer: A systematic review and meta-analysis. Frontiers in Oncology. 12. 978823–978823. 10 indexed citations
11.
Cai, Chen, Gaofeng Ni, Jun Xia, et al.. (2022). Response of the Anaerobic Methanotrophic Archaeon Candidatus “Methanoperedens nitroreducens” to the Long-Term Ferrihydrite Amendment. Frontiers in Microbiology. 13. 799859–799859. 14 indexed citations
12.
Li, Liming, Wenpeng Huang, Ping Hou, et al.. (2022). A computed tomography-based preoperative risk scoring system to distinguish lymphoepithelioma-like gastric carcinoma from non-lymphoepithelioma-like gastric carcinoma. Frontiers in Oncology. 12. 872814–872814. 1 indexed citations
13.
Li, Weiwei, Shigao Huang, Shi Liu, et al.. (2022). Efficacy and safety of PEG-rhG-CSF in preventing chemoradiotherapy-induced neutropenia in patients with locally advanced cervical cancer. SHILAP Revista de lepidopterología. 23(2). 310–316. 6 indexed citations
15.
Hu, Huabin, Zehua Wu, Chao Wang, et al.. (2020). Duration of FOLFOX Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer With Deficient Mismatch Repair. Frontiers in Oncology. 10. 579478–579478. 6 indexed citations
17.
Li, Weiwei, Xiao Lyu, Yan Song, et al.. (2017). Adjuvant chemotherapy with paclitaxel and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma. Chinese Journal of Cancer Research. 29(2). 149–155. 20 indexed citations
18.
Li, Weiwei, et al.. (2013). Dermoscopy in the differential diagnosis of basal cell carcinoma: a preliminary study. Chinese Journal of Dermatology. 46(7). 480–484. 2 indexed citations
19.
Li, Weiwei, et al.. (2011). Bis(μ-2-phenylquinoline-4-carboxylato)bis[aqua(1,10-phenanthroline)(2-phenylquinoline-4-carboxylato)manganese(II)] dihydrate. Acta Crystallographica Section E Structure Reports Online. 67(10). m1464–m1465. 5 indexed citations
20.
Song, Liping, Yueping Li, Ning Wang, et al.. (2009). NT4(Si)-p53(N15)-antennapedia induces cell death in ahuman hepatocellular carcinoma cell line. World Journal of Gastroenterology. 15(46). 5813–5813. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026